Citations 1
A phase I trial of 17-allylamino-geldanamycin (17AAG) in patients with advanced cancer
Erlichman, Charles , Toft, D O, Reid, J., Ames, M. M., Mandrekar, Sumithra J. , Ajei, A., McCollum, Andrea K., Ivy, Percy, Goetz, Matthew P.
Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 3030-3030
